Differential interferences with clinical chemistry assays by gold nanorods, and gold and silica nanospheres

References

• Arnida, Janát-Amsbury MM, Ray A, Peterson CM, Ghandehari H. 2011. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 77:417–23
   PubMed Web of Science ®Google Scholar
• Banfi G, Fabbro MD. 2006. Nanotechnologic nutraceuticals: nurturing or nefarious? Clin Chem 52:331–2
   PubMed Web of Science ®Google Scholar
• Barrett EG, Johnston C, Oberdorster G, Finkelstein JN. 1999. Silica binds serum proteins resulting in a shift of the dose-response for silica-induced chemokine expression in an alveolar Type II cell line. Toxicol Appl Pharmacol 161:111–22
   PubMed Web of Science ®Google Scholar
• Baek M, Chung HE, Yu J, Lee JA, Kim TH, Oh JM, et al. 2012. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomedicine 7:3081–97
   PubMed Web of Science ®Google Scholar
• Belyanskaya L, Manser P, Spohn P, Bruinink A, Wick P. 2007. The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction. Carbon 45:2643–8
   Web of Science ®Google Scholar
• Boverhof DR, David RM. 2010. Nanomaterial characterization: considerations and needs for hazard assessment and safety evaluation. Anal Bioanal Chem 396:953–61
   PubMed Web of Science ®Google Scholar
• Brown DM, Dickson C, Duncan P, Al-Attili F, Stone V. 2010. Interaction between nanoparticles and cytokine proteins: impact of protein and particles functionality. Nanotechnology 21:1–9
   Web of Science ®Google Scholar
• Calzolai L, Gilliland D, Rossi F. 2012. Measuring nanoparticles size distribution in food and consumer products: a review. Food Addit Contam Part A Chem Anal Expo Risk Assess 29:1183–93
   PubMed Web of Science ®Google Scholar
• Casey A, Herzog E, Davoren M, Lyng FM, Byrne HJ, Chambers G. 2007. Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon 45:1425–32
   Web of Science ®Google Scholar
• Dekker S, Krystek P, Peters RJ, Lankveld DPK, Bokkers BGH, Hoeven-Arentzen PHV, et al. 2011. Presence and risks of nanosilica in food products. Nanotoxicology 5:393–405
   PubMed Web of Science ®Google Scholar
• Doak SH, Griffiths SM, Manshian B, Singh N, Williams PM, Brown AP, Jenkins GJS. 2009. Confounding experimental considerations in nanogenotoxicology. Mutagenesis 24:285–93
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. 2008. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487–95
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Neun BW, Clogston JD, Ding H, Ljubimova J, McNeil SE. 2010. Ambiguities in applying traditional Limulus Amebocyte Lysate tests to quantify endotoxin in nanoparticle formulations. Nanomedicine 5:555–62
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, et al. 2009. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomed-Nanotechnol 5:106–17
   PubMed Web of Science ®Google Scholar
• Fischer HC, Chan WC. 2007. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565–71
   PubMed Web of Science ®Google Scholar
• Frens G. 1973. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature (London), Phys Sci 241:20–2
   Web of Science ®Google Scholar
• Hall JB, Dobrovolskaia MA, Patri AK, McNeil SE. 2007. Characterization of nanoparticles for therapeutics. Nanomedicine-UK 2:789–803
   PubMed Web of Science ®Google Scholar
• Hillyer JF, Albretch RM. 2001. Gastrointestinal persorption and tissue distribution of differential sized colloidal gold nanoparticles. J Pharm Sci 90:1927–36
   PubMed Web of Science ®Google Scholar
• Jana NR, Gearheart L, Murphy CJ. 2001. Wet chemical synthesis of high aspect ratio cylindrical gold nanorods. J Phys Chem B 105:4065–7
   Web of Science ®Google Scholar
• Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, et al. 2010. Subchronic oral toxicity of silver nanoparticles. Particle Fibre Toxicol 7:1–11
   PubMed Web of Science ®Google Scholar
• Kroll A, Pillukat MH, Hahn D, Schnekenburger J. 2009. Current in vitro methods in nanoparticle risk assessment: limitations and challenges. Eur J Pharm Biopharm 72:370–7
   PubMed Web of Science ®Google Scholar
• Kroll A, Pillukat MH, Hahn D, Schnekenburger J. 2012. Interference of engineered nanoparticles with in vitro toxicity assays. Arch Toxicol 86:1123–36
   PubMed Web of Science ®Google Scholar
• Landsiedel R, Kapp MD, Schulz M, Wiench K, Oesh F. 2009. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations – many questions, some answers. Mutation Res 681:241–58
   PubMed Web of Science ®Google Scholar
• Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Particle Fibre Toxicol 8:1–14
   PubMed Web of Science ®Google Scholar
• McNeil SE. 2011. Characterization of nanoparticles intended for drug delivery. In Methods in Molecular Biology 697. New York: Humana Press
   Google Scholar
• Mohamed MB, Volkov V, Link S, El-Sayed MA. 2000. The ‘lightning’ gold nanorods: fluorescence enhancement of over a million compared to the gold metal. Chem Phys Lett 317:517–23
   Web of Science ®Google Scholar
• Oostingh GJ, Casals E, Italiani P, Colognato R, Stritzinger R, Ponti J, et al. 2011. Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Particle Fibre Toxicol 8:1–21
   PubMed Web of Science ®Google Scholar
• Schleh C, Semmler-Behnke M, Lipka J, Wenk A, Hirn S, Schäffler M, et al. 2012. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 6:36–46
   PubMed Web of Science ®Google Scholar
• Shinke K, Ando K, Koyana T, Takai T, Nakaji S, Ogino T. 2010. Properties of various carbon nanomaterial surfaces in bilirubin adsorption. Colloids Surf B: Biointerf 77:18–21
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Makino K. 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B: Biointerf 66:274–80
   PubMed Web of Science ®Google Scholar
• Stöber W, Fink A, Bohn E. 1968. Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interf Sci 26:62–9
   Web of Science ®Google Scholar
• Veranth JM, Kaser EG, Veranth MM, Koch M, Yost GS. 2007. Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts. Particle Fibre Toxicol 4:1–18
   PubMedGoogle Scholar
• Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y, et al. 2007. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 168:176–85
   PubMed Web of Science ®Google Scholar
• Zhang XD, Wu HY, Wu D, Wang YY, Chang JH, Zhai ZB, et al. 2010. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomed 5:771–81
   PubMed Web of Science ®Google Scholar